This newsletter is published by Association Revenue Partners

February 16, 2023

Follow us on Twitter   Follow us on LinkedIn   Follow us on YouTube   Follow us on Facebook   Follow us on Instagram


Plan to join your colleagues at the 2023 American Academy of Emergency Nurse Practitioners® (AAENP) National Conference: EmergNP, to be held March 31 - April 2, 2023 in Hempstead, New York. Our return to an in-person venue will offer fast-paced, clinically relevant sessions with additional procedure hours and poster presentations. Mark your calendar now for this unique opportunity to collaborate and learn with your peers!

Highlights include:

  • Two full days of education on Friday and Saturday of the event, including keynote presenters, breakout tracks and evening social hours
  • Procedural Track on Sunday
  • Optional Ultra Sound workshop
  • Over 25 hours of CME available

Registration available on the website!

Not sure what to expect? Selected sessions from last year’s conference are available as FREE CME on our website. Make sure you are logged in as a member, and then check out the offerings at


Call for student members for Membership Committee

Are you a student looking to get more involved with AAENP? The membership committee is now seeking a student member! If interested, please submit your CV and statement of interest here!



Check out the FREE resources for educating patients about COVID. Find them on our website at


4 Things to Know About Treating Patients for COVID

Hospitalizations of patients with COVID have been ticking upward since the fall of 2022. We can keep more people out of the hospital and from dying by educating our patients about treatment options for people at increased risk for severe COVID illness. Here are 4 things to keep in mind about treating patients for COVID:

  1. Physicians and other authorized health care providers are being advised to treat high-risk patients—even if their symptoms are mild—to reduce their chances of severe illness, hospitalization, or death.
  2. Priority patients for treatment are those 50 and older (especially those over 65) and those with underlying conditions that put them at increased risk for COVID complications.
  3. Knowing a patient’s medical history and current medications is critical to guide treatment options.
  4. Treatment for high-risk eligible patients must begin within 5 to 7 days of symptom onset, depending on the treatment.

Effectiveness of treatments against Omicron subvariants

Currently authorized or approved treatments for COVID are expected to continue to be active against the currently circulating Omicron subvariants. Federal health agencies are monitoring data and will issue alerts and recommendations as needed to help physicians provide their patients with the best and most effective treatment possible.

Vaccination remains the best protection

The best advice we can still give our patients is to stay up to date with their COVID vaccine—that includes getting an updated bivalent COVID vaccine as soon as they’re eligible.

Wearing masks in indoor public settings where the risk that COVID poses to the community is high also helps protect our patients.


Interested in sharing your expertise as a speaker or representative on workgroups with other organizations? Let us know your interest by completing our Speaker’s Bureau Form.



Mark your calendars now for our NEXT 2023 AAENP/AENJ Journal Club on May 9, 2023! Make plans to attend the quarterly Journal Clubs at 8 PM EST. Registration coming soon!


Member Highlight: Lily Haboush- AAENP Oregon State Representative  

Lily completed her Master of Science in Nursing at Vanderbilt University in 2017 followed by her Doctor of Nursing Practice at Oregon Health & Sciences University in 2020.  Her project topic and special interest is Anti-racism training for healthcare students, and she is devoted to innovative teaching styles. She has taught at the University of Portland, OHSU, and University of South Alabama.  She currently practices at Providence St. Vincent’s, Portland’s busiest emergency department. When not teaching or seeing patients, she enjoys time with her daughter and their new bernedoodle puppy!  

Looking for a deeper dive into EM concepts and care?

Learn with EMCT by going to the virtual bedside. Earn procedural, pharmacologic, and even trauma CE as you enhance your practice of emergency medicine. Send a request to for a link to this full free epistaxis lesson, or purchase an 18 or 24 month subscription at 45% off by going to and putting in the promo code EMCT45 at checkout. EMCT is experiential learning and has the most comprehensive online EM training available.

What the Buprenorphine X-Waiver Removal Means for Clinicians

Prescribing buprenorphine for opioid use disorder just got easier. The DATA-Waiver (X-Waiver) Program was eliminated on December 29, 2022, with President Biden’s signing of the Consolidated Appropriations Act...

Current Practices and Nurse Readiness to Implement Standardized Screening for Commercially and Sexually Exploited Individuals in Emergency Departments in Western Washington Hospitals

Approximately 80% of trafficked individuals access health care during their victimization. The emergency department is a frontline of care. This study examines current screening practices of Western Washington...


Looking for a way to get involved at AAENP? State Representatives are essential connections to our members and actively support the values and mission of AAENP. State Representative needs are as follows: Alaska, Connecticut, Delaware, Maine, Montana, New Jersey, North Dakota, South Carolina, Washington DC, and Puerto Rico. If interested, please apply through the AAENP website at


ICYMI – Some members have missed the prior newsletters sent out monthly this year. You can find some below.




To ensure you are receiving ENP VOICE, please click here to subscribe.

If you know of colleagues not receiving the newsletter, have them email for assistance.  



Association Revenue Partners

A JSJD Media Company

500 N. Central Expy, Suite 231, Plano, TX 75074

*This publication does not represent the thoughts or opinions of JSJD Media and is intended as an aggregation of published news content only